Urteste S.A. (URT.WA) — Stock Score Summary

Urteste S.A. (URT.WA) has a MoatMap StockRank of 33/100 based on Quality (33/100), Value (39/100), and Momentum (49/100) factor scores. The current signal is SELL. Urteste is an early-stage Polish medical diagnostics company. It is pre-revenue, highly speculative, and lacks the validated commercial platform or CDMO pricing power required to meet our quality standards.

Urteste S.A. is a biotechnology company developing innovative, non-invasive diagnostics for the early detection of cancers from urine samples. The company's proprietary technology platform measures the activity of specific enzymes associated with tumor progression. Its competitive moat is secured by a broad international patent portfolio and a highly differentiated, cost-effective diagnostic approach.

Key Financial Metrics

Price$12.21
Market Cap$18M
Price/Book2.51
Return on Equity-30.0%
Return on Invested Capital-16.3%
Debt/Equity12.20
Gross Margin91.2%
Operating Margin-254.1%
Revenue Growth-1.3%
Free Cash Flow$-945K

Urteste S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Urteste S.A.’s (URT.WA) StockRank?
MoatMap’s StockRank for Urteste S.A. (URT.WA) is 33/100, with a Sell signal. It is a composite of Quality (33), Value (39), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does Urteste S.A. have an economic moat?
Urteste S.A. (URT.WA) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Urteste S.A. a buy, hold, or sell?
MoatMap’s current signal for Urteste S.A. (URT.WA) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Urteste S.A. in?
Urteste S.A. (URT.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksURT.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock